Design of the ß3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.
JACC Basic Transl Sci
; 5(4): 317-327, 2020 Apr.
Article
en En
| MEDLINE
| ID: mdl-32368692
CCT, cardiac computed tomography; CMR, cardiac magnetic resonance; CpcPH, combined pre- and post-capillary pulmonary hypertension; ECG, electrocardiography; HF, heart failure; ITT, intention to treat; IpcPH, isolated post-capillary pulmonary hypertension; LHD, left heart disease; LV, left ventricular; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; NYHA, New York Heart Association; PAP, pulmonary artery pressure; PH, pulmonary hypertension; PP, Per protocol; PVR, pulmonary vascular resistance; RV, right ventricle; adrenoreceptors; cGMP, cyclic guanosine monophosphate; imaging; pulmonary hypertension; treatment; ß3AR, beta-3 adrenoreceptor
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
JACC Basic Transl Sci
Año:
2020
Tipo del documento:
Article
País de afiliación:
España
Pais de publicación:
Estados Unidos